WELLESLEY HILLS, Mass., Jan. 28 /CNW/ -- Joseph F. Finn, Jr., CPA, the
Assignee for the Benefit of Creditors of ActivBiotics, today announced the
completion the sale of the Company's fixed assets for in excess of
$300,000 through an auction on January 24th. In addition, due to the high
volume of requests for due diligence materials from prospective buyers for the
purchase of the intellectual property, the Company has created an online
datasite that allows access to confidential information pertinent to each of
the three assets: Rifalazil, antibacterial NCEs, and superoxide dismutase
small molecule mimetics.
